The Accuracy of an Electronic Multidose Dry Powder Inhaler (eMDPI) to Measure Inhalation Parameters When Used by Patients

被引：0

作者：

Chrystyn, H. ^{[1
]}

Saralaya, D. ^{[2
,3
]}

Shenoy, A. ^{[2
,3
]}

Toor, S. ^{[4
]}

Kastango, K. ^{[5
]}

Calderon, E. ^{[6
]}

Safioti, G. ^{[7
]}

机构：

[1] Inhalat Consultancy Ltd, Leeds, W Yorkshire, England

[2] Bradford Teaching Hosp NHS Fdn Trust, Bradford, W Yorkshire, England

[3] Bradford Inst Hlth Res, Bradford, W Yorkshire, England

[4] Resp Matters, Huddersfield, W Yorkshire, England

[5] QuintilesIMS, Cambridge, MA USA

[6] Teva Pharmaceut Ind, Waterford, Ireland

[7] Teva Pharmaceut Ind, Amsterdam, Netherlands

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A3942

引用

页数：2

共 50 条

[41] Inter- and intra- variability of inhalation rates when patients use their dry powder inhalers (DPIs)
Tarsin, W
Hawksworth, G
Haslam, GH
Chrystyn, H
THORAX, 2001, 56 : 64 - 64
[42] Numerical simulation of the effect of inhalation parameters and disease severity on the deposition of dry powder aerosol drugs in COPD patients
Farkas, Arpad
Horvath, Alpar
Tomisa, Gabor
Galffy, Gabriella
Varga, Janos
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[43] Wixela™ Inhub™ dry powder inhaler: In vitro performance compared with Advair Diskus® and inhalation profiles in patients with asthma or chronic obstructive pulmonary disease
Cooper, Andrew
Newcomb, Claire
Ward, Jonathan K.
Allan, Richard
Wallace, Roisin
ALLERGY AND ASTHMA PROCEEDINGS, 2019, 40 (05) : 360 - 360
[44] Wixela® Inhub® Dry Powder Inhaler - In Vitro Performance Compared with Advair Diskus and Inhalation Profiles in Patients with Asthma or Chronic Obstructive Pulmonary Disease
Cooper, A.
Newcomb, C.
Wallace, R.
Canham, K.
Ward, J.
Allan, R.
Berry, M.
Parker, J.
Clift, E.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[45] In-Vitro Delivery Performance Of Umeclidinium And Umeclidinium/vilanterol From A Dry Powder Inhaler Using The Electronic Lung Breathing Simulator To Replicate Inhalation Profiles From Patients With Varying COPD Severity
Hamilton, M.
Prime, D.
Heuscar, M. Bogalo
Pang, C.
Charles, S.
Gillett, B.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
[46] Clinical Response and Cost-Savings Associated With Generic Fluticasone Propionate/Salmeterol Multidose, Dry-Powder Inhaler in Asthma Patients Managed in an Ambulatory Care Practice Setting
McCarthy, Patrick
Iliadis, Tanya
Zaiken, Kathy
JOURNAL OF PHARMACY PRACTICE, 2022, 35 (02) : 274 - 280
[47] Novel albuterol multidose dry powder inhaler in patients with exercise-induced bronchoconstriction: A single-dose, double-blind, randomized, 2-way crossover study
Ostrom, Nancy K.
Taveras, Herminia
Iverson, Harald
Pearlman, David S.
RESPIRATORY MEDICINE, 2015, 109 (11) : 1410 - 1415
[48] Rescue-free and symptom-free days with mometasone furoate dry powder inhaler used once or twice daily in the evening by patients with persistent asthma
Bensch, G. W.
Corren, J.
Lockey, R.
Yao, R.
Staudinger, H.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S173 - S173
[49] In-vitro product performance of fluticasone furoate (FF)/umeclidinium (UMEC)/vilanterol (VI) delivered from a dry powder inhaler (DPI) using the Electronic Lung (EL) to replicate patient inhalation profiles
Prime, D.
Hamilton, M.
Taylor, E.
PNEUMOLOGIE, 2020, 74 : S44 - S45
[50] In-vitro product performance of fluticasone furoate (FF)/umeclidinium (UMEC)/vilanterol (VI) delivered from a dry powder inhaler (DPI) using the Electronic Lung (EL) to replicate patient inhalation profiles
Prime, David
Hamilton, Melanie
Taylor, Edward
EUROPEAN RESPIRATORY JOURNAL, 2019, 54

← 1 2 3 4 5 →